Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 18;83(10):1693-1709.e9.
doi: 10.1016/j.molcel.2023.04.021.

Unconventional initiation of PINK1/Parkin mitophagy by Optineurin

Affiliations
Free article

Unconventional initiation of PINK1/Parkin mitophagy by Optineurin

Thanh Ngoc Nguyen et al. Mol Cell. .
Free article

Abstract

Cargo sequestration is a fundamental step of selective autophagy in which cells generate a double-membrane structure termed an "autophagosome" on the surface of cargoes. NDP52, TAX1BP1, and p62 bind FIP200, which recruits the ULK1/2 complex to initiate autophagosome formation on cargoes. How OPTN initiates autophagosome formation during selective autophagy remains unknown despite its importance in neurodegeneration. Here, we uncover an unconventional path of PINK1/Parkin mitophagy initiation by OPTN that does not begin with FIP200 binding or require the ULK1/2 kinases. Using gene-edited cell lines and in vitro reconstitutions, we show that OPTN utilizes the kinase TBK1, which binds directly to the class III phosphatidylinositol 3-kinase complex I to initiate mitophagy. During NDP52 mitophagy initiation, TBK1 is functionally redundant with ULK1/2, classifying TBK1's role as a selective autophagy-initiating kinase. Overall, this work reveals that OPTN mitophagy initiation is mechanistically distinct and highlights the mechanistic plasticity of selective autophagy pathways.

Keywords: OPTN; PINK1; Parkin; TBK1; autophagosome; autophagy; selective autophagy.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.M. is a member of the scientific advisory board of Casma Therapeutics. M.L. is a member of the scientific advisory board and co-founder of Automera.

Publication types

MeSH terms

Substances

LinkOut - more resources